Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Related Citations for PubMed (Select 16083255)

1.

Correcting common errors in identifying cancer-specific serum peptide signatures.

Villanueva J, Philip J, Chaparro CA, Li Y, Toledo-Crow R, DeNoyer L, Fleisher M, Robbins RJ, Tempst P.

J Proteome Res. 2005 Jul-Aug;4(4):1060-72.

2.

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry.

Villanueva J, Philip J, Entenberg D, Chaparro CA, Tanwar MK, Holland EC, Tempst P.

Anal Chem. 2004 Mar 15;76(6):1560-70.

PMID:
15018552
3.

Serum peptide profiling: identifying novel cancer biomarkers for early disease detection.

Martorella A, Robbins R.

Acta Biomed. 2007;78 Suppl 1:123-8.

PMID:
17465330
4.

A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery.

Villanueva J, Nazarian A, Lawlor K, Yi SS, Robbins RJ, Tempst P.

Mol Cell Proteomics. 2008 Mar;7(3):509-18. Epub 2007 Nov 6.

5.

Serum peptidome patterns that distinguish metastatic thyroid carcinoma from cancer-free controls are unbiased by gender and age.

Villanueva J, Martorella AJ, Lawlor K, Philip J, Fleisher M, Robbins RJ, Tempst P.

Mol Cell Proteomics. 2006 Oct;5(10):1840-52. Epub 2006 Aug 8.

6.

High-resolution serum proteomic features for ovarian cancer detection.

Conrads TP, Fusaro VA, Ross S, Johann D, Rajapakse V, Hitt BA, Steinberg SM, Kohn EC, Fishman DA, Whitely G, Barrett JC, Liotta LA, Petricoin EF 3rd, Veenstra TD.

Endocr Relat Cancer. 2004 Jun;11(2):163-78.

7.

A database application for pre-processing, storage and comparison of mass spectra derived from patients and controls.

Titulaer MK, Siccama I, Dekker LJ, van Rijswijk AL, Heeren RM, Sillevis Smitt PA, Luider TM.

BMC Bioinformatics. 2006 Sep 5;7:403.

8.

Data analysis of assorted serum peptidome profiles.

Villanueva J, Philip J, DeNoyer L, Tempst P.

Nat Protoc. 2007;2(3):588-602.

PMID:
17406620
9.

A new approach for the analysis of mass spectrometry data for biomarker discovery.

Barbarini N, Magni P, Bellazzi R.

AMIA Annu Symp Proc. 2006:26-30.

10.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
11.

Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.

Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M.

Clin Chem Lab Med. 2009;47(6):713-23. doi: 10.1515/CCLM.2009.158.

PMID:
19426140
12.

Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.

Callesen AK, Christensen Rd, Madsen JS, Vach W, Zapico E, Cold S, Jørgensen PE, Mogensen O, Kruse TA, Jensen ON.

Rapid Commun Mass Spectrom. 2008;22(3):291-300. doi: 10.1002/rcm.3364.

PMID:
18181248
13.

High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures.

Lopez MF, Mikulskis A, Kuzdzal S, Bennett DA, Kelly J, Golenko E, DiCesare J, Denoyer E, Patton WF, Ediger R, Sapp L, Ziegert T, Lynch C, Kramer S, Whiteley GR, Wall MR, Mannion DP, Della Cioppa G, Rakitan JS, Wolfe GM.

Clin Chem. 2005 Oct;51(10):1946-54. Epub 2005 Aug 4.

14.

Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.

Pietrowska M, Marczak L, Polanska J, Behrendt K, Nowicka E, Walaszczyk A, Chmura A, Deja R, Stobiecki M, Polanski A, Tarnawski R, Widlak P.

J Transl Med. 2009 Jul 13;7:60. doi: 10.1186/1479-5876-7-60.

15.

Serum peptide profiling using MALDI mass spectrometry: avoiding the pitfalls of coated magnetic beads using well-established ZipTip technology.

Tiss A, Smith C, Camuzeaux S, Kabir M, Gayther S, Menon U, Waterfield M, Timms J, Jacobs I, Cramer R.

Proteomics. 2007 Sep;7 Suppl 1:77-89. Review.

PMID:
17893856
16.

Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.

Wang QT, Li YZ, Liang YF, Hu CJ, Zhai YH, Zhao GF, Zhang J, Li N, Ni AP, Chen WM, Xu Y.

Anat Rec (Hoboken). 2009 Apr;292(4):604-10. doi: 10.1002/ar.20871.

17.

Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).

Yang J, Song YC, Song TS, Hu XY, Guo YM, Li ZF, Dang CX, Huang C.

J Clin Lab Anal. 2012 May;26(3):148-54. doi: 10.1002/jcla.21502.

PMID:
22628229
18.

Improved classification of breast cancer peptide and protein profiles by combining two serum workup procedures.

Velstra B, van der Burgt YE, Mertens BJ, Mesker WE, Deelder AM, Tollenaar RA.

J Cancer Res Clin Oncol. 2012 Dec;138(12):1983-92. doi: 10.1007/s00432-012-1273-4. Epub 2012 Jul 5.

19.
20.

MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.

Cazares LH, Diaz JI, Drake RR, Semmes OJ.

Methods Mol Biol. 2008;428:125-40.

PMID:
18287771
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk